MX366667B - Moléculas y mecanismos inducidos durante la infección con dengue que participan en la patogenia viral. - Google Patents

Moléculas y mecanismos inducidos durante la infección con dengue que participan en la patogenia viral.

Info

Publication number
MX366667B
MX366667B MX2014015561A MX2014015561A MX366667B MX 366667 B MX366667 B MX 366667B MX 2014015561 A MX2014015561 A MX 2014015561A MX 2014015561 A MX2014015561 A MX 2014015561A MX 366667 B MX366667 B MX 366667B
Authority
MX
Mexico
Prior art keywords
participate
molecules
induced during
dengue infection
mechanisms induced
Prior art date
Application number
MX2014015561A
Other languages
English (en)
Other versions
MX2014015561A (es
Inventor
Soto Acosta Rubén
María Del Ángel Nuñez Rosa
Original Assignee
Centro De Investig Y De Estudios Avanzados Del I P N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investig Y De Estudios Avanzados Del I P N filed Critical Centro De Investig Y De Estudios Avanzados Del I P N
Priority to MX2014015561A priority Critical patent/MX366667B/es
Publication of MX2014015561A publication Critical patent/MX2014015561A/es
Publication of MX366667B publication Critical patent/MX366667B/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere al campo de la farmacología y describe y provee de los elementos para proponer al ácido nordihidroguayarético (NDGA) o derivados del mismo, como un agente antiviral para inhibir al virus del dengue (DENV), provee de las composiciones que comprendan NDGA y provee de los elementos para realizar profilaxis o el tratamiento eficaz en paciente con síntomas de dengue clásico o bien con dengue hemorrágico, infectado por cualquier serotipo de DENV, de preferencia de tipo 2 ó 4.
MX2014015561A 2014-12-16 2014-12-16 Moléculas y mecanismos inducidos durante la infección con dengue que participan en la patogenia viral. MX366667B (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2014015561A MX366667B (es) 2014-12-16 2014-12-16 Moléculas y mecanismos inducidos durante la infección con dengue que participan en la patogenia viral.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014015561A MX366667B (es) 2014-12-16 2014-12-16 Moléculas y mecanismos inducidos durante la infección con dengue que participan en la patogenia viral.

Publications (2)

Publication Number Publication Date
MX2014015561A MX2014015561A (es) 2016-06-15
MX366667B true MX366667B (es) 2019-07-12

Family

ID=57217122

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014015561A MX366667B (es) 2014-12-16 2014-12-16 Moléculas y mecanismos inducidos durante la infección con dengue que participan en la patogenia viral.

Country Status (1)

Country Link
MX (1) MX366667B (es)

Also Published As

Publication number Publication date
MX2014015561A (es) 2016-06-15

Similar Documents

Publication Publication Date Title
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
PH12015500724B1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
EA201690556A1 (ru) Способы и фармацевтические композиции для лечения вызванных вирусом гепатита в инфекций
PH12015502230B1 (en) Novel viral replication inhibitors
BR112016024096A2 (pt) novo bacteriófago e composição compreendendo o mesmo
MX2017003928A (es) Composiciones farmaceuticas de accion prolongada.
MX2019004029A (es) Compuestos y metodos para diagnosis y tratamiento de infecciones virales.
EA201592242A1 (ru) Производные пиридона для лечения вирусных инфекций и других заболеваний
PH12017500817A1 (en) Long acting pharmaceutical compositions for hepatitis c
PH12017500820A1 (en) Combination long acting compositions and methods for hepatitis c
PH12017501943B1 (en) Influenza virus neutralizing peptidomimetic compounds
MX366667B (es) Moléculas y mecanismos inducidos durante la infección con dengue que participan en la patogenia viral.
EA201792083A1 (ru) Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний

Legal Events

Date Code Title Description
FG Grant or registration